Furthermore, antibodies titres attained after the immunization protocol were not very high, when compared to antibodies titres after common infectious diseases, which is also reassuring in safety concerns, since complete neutralization of ghrelin was not the purpose of an anti-ghrelin vaccination strategy for obesity treatment as ghrelin also intervenes in several key biological processes besides appetite regulation, such as growth hormone secretion, gastro-intestinal and cardiovascular functions [29]. The gene discussed is GH1; the disease is obesity disorder.